Huasheng Yihong Investment Management

Overview

Huasheng Yihong Investment Management is a Chinese private equity firm based in Shenzhen, Guangdong, China. The firm specializes in post-IPO equity investments, focusing on sectors such as biotechnology, venture capital, software, information technology, information services, artificial intelligence, health care, big data, medical, and banking. Their investment strategy encompasses various stages, including seed, early stage, Series A, Series B, growth, late stage, pre-IPO, buyout, turnaround, and distressed investments. The firm's geographical focus is primarily on China. Huasheng Yihong Investment Management has a track record of leading and participating in multiple funding rounds, with an average round size between $1 million and $5 million. Their portfolio includes companies like Chi Biomedicine, Innovisgroup, and Yorktal. The firm's investment philosophy emphasizes value investing, seeking high-quality opportunities that can navigate through market cycles. They have demonstrated a commitment to supporting companies across different stages of growth, from early-stage ventures to post-IPO entities, aiming to achieve long-term value creation for their investors and portfolio companies.

Investment Focus

• High-quality investment opportunities
• Companies with potential for long-term value creation
• Businesses capable of navigating through market cycles

Portfolio Companies